BioMarin Pharmaceutical Inc. Stock Forecast
BioMarin Pharmaceutical Inc. stock price ended at $90.87 on Tuesday, after losing 0.699%.
(Updated on Apr 16, 2024)
The BioMarin Pharmaceutical Inc. stock price fell by -0.699% on the last day (Tuesday, 16th Apr 2024) from $91.51 to $90.87. During the last trading day the stock fluctuated 1.80% from a day low at $90.16 to a day high of $91.78. The price has risen in 7 of the last 10 days and is up by 4.69% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -700 thousand shares and in total, 1 million shares were bought and sold for approximately $109.70 million.
The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $92.10 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -3.92% during the next 3 months and, with a 90% probability hold a price between $79.36 and $88.49 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
BMRN Signals & Forecast
The BioMarin Pharmaceutical Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $90.36 and $87.13. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -1.46%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock
BioMarin Pharmaceutical Inc. finds support from accumulated volume at $90.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.62 between high and low, or 1.80%. For the last week, the stock has had daily average volatility of 2.46%.
Our recommended stop-loss: $87.05 (-4.21%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 2 days ago.)
Trading Expectations (BMRN) For The Upcoming Trading Day Of Wednesday 17th
For the upcoming trading day on Wednesday, 17th we expect BioMarin Pharmaceutical Inc. to open at $90.94, and during the day (based on 14 day Average True Range), to move between $89.10 and $92.64, which gives a possible trading interval of +/-$1.77 (+/-1.94%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 3.89% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $91.24 (0.41%) than the support at $90.21 (0.73%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is BioMarin Pharmaceutical Inc. stock A Buy?
BioMarin Pharmaceutical Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: -0.218 Hold/Accumulate Unchanged
Predicted Opening Price for BioMarin Pharmaceutical Inc. of Wednesday, April 17, 2024
| Fair opening price April 17, 2024 | Current price |
|---|---|
| $90.94 ( 0.0734%) | $90.87 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BMRN
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 92.56 | 1.86 % | |
| R2 | 91.94 | 1.18 % | ||
| R1 | 91.56 | 0.754 % | ||
| Current price: | 90.87 | |||
| Support | S1 | 90.32 | -0.608 % | |
| S2 | 89.94 | -1.03 % | ||
| S3 | 89.32 | -1.71 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 92.22 | 1.49 % | |
| R2 | 91.46 | 0.649 % | ||
| R1 | 91.24 | 0.407 % | ||
| Current price | 90.87 | |||
| Support | S1 | 90.21 | -0.726% | |
| S2 | 89.66 | -1.33% | ||
| S3 | 86.28 | -5.05% |
FAQ
Click here for our free guide on how to buy BioMarin Pharmaceutical Inc. Stock.
